These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33731590)

  • 41. Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Vural Keskinler M; Mutlu HH; Sirin A; Erkalma Senates B; Colak Y; Tuncer I; Oguz A
    Metab Syndr Relat Disord; 2021 Feb; 19(1):26-31. PubMed ID: 32898457
    [No Abstract]   [Full Text] [Related]  

  • 42. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.
    Parikh P; Patel J; Ingle M; Sawant P
    Indian J Gastroenterol; 2015 May; 34(3):200-8. PubMed ID: 26108652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease.
    Sunbul M; Kivrak T; Durmus E; Akin H; Aydin Y; Ergelen R; Yilmaz Y; Agirbasli M
    Cardiovasc Ther; 2015 Oct; 33(5):294-9. PubMed ID: 26202098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Kowdley KV; Belt P; Wilson LA; Yeh MM; Neuschwander-Tetri BA; Chalasani N; Sanyal AJ; Nelson JE;
    Hepatology; 2012 Jan; 55(1):77-85. PubMed ID: 21953442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CT Texture Analysis in Nonalcoholic Fatty Liver Disease (NAFLD).
    Dichtel LE; Tabari A; Mercaldo ND; Corey KE; Husseini J; Osganian SA; Chicote ML; Rao EM; Miller KK; Bredella MA
    J Clin Exp Hepatol; 2023; 13(5):760-766. PubMed ID: 37693260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.
    Rudolph B; Bjorklund N; Ovchinsky N; Kogan-Liberman D; Perez A; Liszewski M; Levin TL; Ewart M; Liu Q; Xue X; Viswanathan S; Strickler HD
    Contemp Clin Trials; 2018 Dec; 75():51-58. PubMed ID: 30401631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Rosenblatt R; Mehta A; Snell D; Hissong E; Kierans AS; Kumar S
    Dig Dis Sci; 2019 Jan; 64(1):262-268. PubMed ID: 30269271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
    Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease.
    Petta S; Tuttolomondo A; Gagliardo C; Zafonte R; Brancatelli G; Cabibi D; Cammà C; Di Marco V; Galvano L; La Tona G; Licata A; Magliozzo F; Maida C; Marchesini G; Merlino G; Midiri M; Parrinello G; Torres D; Pinto A; Craxì A
    Medicine (Baltimore); 2016 Apr; 95(16):e3446. PubMed ID: 27100443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
    Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study.
    Karabay CY; Kocabay G; Kalayci A; Colak Y; Oduncu V; Akgun T; Kalkan S; Guler A; Kirma C
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):325-31. PubMed ID: 24161963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.